Diamond Mine in Canada's North Halted With Hundreds Laid Off
Chief Executive Officer Jeremy King said the company has temporarily suspended its Point Lake open-pit mine after record-low global diamond prices made the operation uneconomical.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Investors in Sygnia (JSE:SYG) have seen impressive returns of 278% over the past five years
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But when you pick a company that is really flourishing, you can make more than 100%. For instance, the price of Sygnia Limited (JSE:SYG) stock is up an impressive 128% over the last five years. On top of that, the share price is up 32% in about a quarter. Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). Over half a decade, Sygnia managed to grow its earnings per share at 15% a year. So the EPS growth rate is rather close to the annualized share price gain of 18% per year. Therefore one could conclude that sentiment towards the shares hasn't morphed very much. Rather, the share price has approximately tracked EPS growth. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. This free interactive report on Sygnia's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. What About Dividends? When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR is a return calculation that accounts for the value of cash dividends (assuming that any dividend received was reinvested) and the calculated value of any discounted capital raisings and spin-offs. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. We note that for Sygnia the TSR over the last 5 years was 278%, which is better than the share price return mentioned above. The dividends paid by the company have thusly boosted the total shareholder return. A Different Perspective We're pleased to report that Sygnia shareholders have received a total shareholder return of 58% over one year. And that does include the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 30% per year), it would seem that the stock's performance has improved in recent times. In the best case scenario, this may hint at some real business momentum, implying that now could be a great time to delve deeper. It's always interesting to track share price performance over the longer term. But to understand Sygnia better, we need to consider many other factors. For example, we've discovered 2 warning signs for Sygnia that you should be aware of before investing here. If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on South African exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Associated Press
43 minutes ago
- Associated Press
Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
VANCOUVER, BC / ACCESS Newswire / July 21, 2025 / Onco-Innovations Limited(CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ) ('Onco' or the 'Company') is pleased to announce the appointment of Dr. Dennis Hall, Professor of Chemistry at the University of Alberta, to its Scientific and Clinical Advisory Board. Dr. Hall is internationally recognized for his pioneering work in organoboron chemistry, catalysis, and medicinal chemistry, including the development of DNA repair inhibitors. He currently holds the Tier 1 Canada Research Chair in Boron Chemistry for Catalysis and Drug Discovery, and leads a multidisciplinary research team dedicated to the development of novel synthetic and biological applications of boron-containing compounds.[1] With over 175 peer-reviewed publications, two books, and 15 book chapters, Dr. Hall's contributions span catalysis, heterocyclic chemistry, and medicinal chemistry. He has mentored more than 75 graduate students and postdoctoral fellows, and his work has been widely cited with over 18,000 citations and an h-index of 70.[2] Among his numerous accolades are the Arthur C. Cope Scholar Award (2024) from the American Chemical Society[3], the R. U. Lemieux Award (2021) from the Canadian Society for Chemistry[4], and a Killam Research Fellowship (2019-2021). He was elected a Fellow of the Royal Society of Canada in 2017. [5] As part of his role, Dr. Hall will serve on the Scientific and Clinical Advisory Board and provide strategic advice to the Company on its Research and Development agenda, including clinical discovery, synthesis and manufacturing, pre-clinical testing, and clinical translation plans associated with Polynucleotide Kinase 3 Phosphatase (PNKP) Inhibitor Technology NP/A83. He will also collaborate with the Company's scientific and clinical leadership, as well as external partners, to advance oncology-focused innovations. 'Dr. Hall's appointment marks a significant step in bridging advanced synthetic chemistry with translational oncology. His expertise in boron-based drug discovery is uniquely aligned with our mission to develop precision therapies, and we look forward to leveraging his insight as we push our PNKP Inhibitor Technology toward the clinic,' stated Thomas O'Shaughnessy, CEO of Onco-Innovations. About Onco-Innovations Limited Onco-Innovations is a Canadian-based company dedicated to cancer research and treatment, specializing in oncology. Onco's mission is to pursue the prevention and treatment of cancer through pioneering research and innovative solutions. The company has secured an exclusive worldwide license to patented technology that targets solid tumours. ON BEHALF OF ONCO-INNOVATIONS LIMITED, 'Thomas O'Shaughnessy' Chief Executive Officer For more information, please contact: Thomas O'Shaughnessy Chief Executive Officer Tel: + 1 888 261 8055 [email protected] Forward-Looking Statements Caution. This news release contains forward-looking statements relating to the further development, potential commercialization and benefits of the Company's technologies, the prospects of the Company, and the Company's business and plans generally, and other statements that are not historical facts. Forward-looking statements are often identified by terms such as 'will', 'may', 'potential', 'should', 'anticipate', 'expects' and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the failure to further develop, prove out or commercialize its technologies, and other risks detailed from time to time in the filings made by the Company with securities regulators. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law. [1] [2] [3] [4] [5] SOURCE: Onco-Innovations Limited press release
Yahoo
an hour ago
- Yahoo
U.S. commerce secretary dismisses question that free trade with Canada is dead
U.S. Commerce Secretary Howard Lutnick is dismissing the question of whether U.S. free trade with Canada is dead, calling the notion "silly" and saying a substantial amount of Canadian goods enter the U.S. tariff-free under the current North American free trade deal. "We have a plan called [the United States-Mexico-Canada Agreement], virtually 75 per cent of all goods coming from Mexico and Canada are already coming tariff-free," Lutnick said in an interview on Face the Nation that aired Sunday morning on CBS. But in the same breath, Lutnick suggested tariffs on Canada are here to stay, for now. "The president understands that we need to open the markets. Canada is not open to us. They need to open their market. Unless they're willing to open their market, they're going to pay a tariff," he added. The commerce secretary's comments come days after Prime Minister Mark Carney told reporters in French there's "not a lot of evidence right now" that the U.S. is willing to cut a deal with Canada without some tariffs included. WATCH | Carney says 'not a lot of evidence' for tariff-free deal: But the prime minister also said on Tuesday that Canada has "almost free trade" with the U.S. — a reference to tariff exemptions granted to Canadian goods that are compliant with USMCA, known as the Agreement (CUSMA) among Canadians. According to an RBC report released last month, approximately 79 per cent of U.S. imports from Canada were "explicitly duty free" in January 2025. That figure rose to approximately 89 per cent in April. "Why should we have our country be wide open while theirs is closed? This is an 80-year wrong that President Trump is trying to fix, and our businesses are going to really, really enjoy it," Lutnick told host Margaret Brennan. CUSMA negotiations looming Lutnick also told Brennan that Trump "is absolutely going to renegotiate [CUSMA], but that's a year from today." "It makes perfect sense for the president to renegotiate it. He wants to protect American jobs. He doesn't want cars built in Canada or Mexico when they could be built in Michigan or Ohio. It's just better for American workers," he added. CUSMA is not officially up for renegotiation until 2026, but some Canadian business leaders and others have called on the federal government to kick-start talks for the sake of economic stability. There are also lingering questions over whether negotiations will yield another trilateral trade pact. Last November, Ontario Premier Doug Ford pitched ditching Mexico and signing a bilateral deal with the United States — a move Alberta Premier Danielle Smith agreed was worth exploring. That suggestion sent a chill through Canada-Mexico relations, but Carney and Mexican President Claudia Sheinbaum appear to be closing the gap. The two leaders met with each other in June during the G7 summit in Kananaskis, Alta., and "looked forward to meeting again in Mexico in the coming months," according to a news release published on the prime minister's website. Canada-U.S. trade talks continue Carney and his negotiating team continue to work toward a deal with Trump in hopes of avoiding the U.S. president's latest threat — a 35 per cent tariff on all Canadian goods. The U.S. president made the threat in a letter he posted on social media that was addressed to the prime minister. He said the tariffs would come into effect on Aug. 1 and that the United States would increase levies if Canada retaliates. Lutnick said the White House will cut better deals with large countries that open their economies "to ranchers, fishermen, farmers and businesses," but if they keep tariff barriers in place then "it seems fair" to impose levies. WATCH | Trump threatens 35 per cent tariffs on Canadian goods: In his letter, Trump cited fentanyl "pouring" into the U.S. from Canada as the reason for his latest tariff threat, even though data continues to show minimal amounts of the drug are crossing the Canada-U.S. border compared to the U.S.-Mexico border. Trump also took a shot at Canada's supply management system, a long-standing irritant that he claims leads to Canada imposing tariffs as high as 400 per cent on American dairy products. High Canadian tariffs only apply if the agreed tariff-rate quotas on U.S. dairy imports under USMCA are reached or exceeded. The U.S.-based International Dairy Association says the Americans have never gotten close to exceeding quotas, but also claims it's because of "protectionist measures" from Canada that limit exports. The Liberal government has maintained it will not dismantle supply management.
